1,338
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy

, , &
Pages 576-583 | Accepted 09 Jun 2011, Published online: 06 Jul 2011

References

  • Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension 2004;44:398-404
  • National Institute for Health and Clinical Excellence. Management of hypertension in adults in primary care. Partial update of Clinical Guideline No. 18. NICE Clinical Guideline, 2006:34
  • Fung V, Huang J, Brand R, et al. Hypertension treatment in a Medicare population: adherence and systolic blood pressure control. Clin Ther 2007;29:972-84
  • The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressures, US Department of Health and Human Services, http://www.nhlbi.nih.gov/guidelines/hypertension/, accessed July 12, 2010
  • Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med 2007;120:713-19
  • Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83
  • Cramer JA and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Medication Compliance and Persistence Work Group. Medication compliance and persistence: Terminology and definitions. Value Health 2008;11:44-7
  • Baser O. Too much ado about propensity score models? Comparing the methods of propensity score matching. Value Health 2006;9:377-85
  • Crown HC, Berndt ER, Baser O, et al. Benefit plan design and prescription drug utilization among asthmatics: do patient co-payments matter? Frontiers in Health Policy Research. Cambridge, MA: MIT Press 2004;7:95-127
  • Baser O. Too much ado about instrumental variable approach: is the cure worse than the disease? Value Health 2009;12:1201-9
  • Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica 1997;65:557-86.
  • Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171
  • Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertension 2001;37:12-18
  • Feldman RD, Zou GY, Vandervoort MK, et al. A simplified approach to the treatment of uncomplicated hypertension. A cluster randomized controlled trial. Hypertension 2009;53:646-53
  • Stukel TA, Fisher ES, Wennberg DE, et al. Analysis of observations studied in the presence of treatment selection bias. JAMA 2007;297:278-85
  • Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.